Study Finds Dual Inhibition Therapy May Lead to Better Outcomes for Aggressive Form of Breast Cancer

A collaboration between the National Cancer Institute (NCI); the Frederick National Laboratory (FNL); and the National University of Ireland, Galway, has shown that two key biomarkers are co-expressed in an aggressive subtype of breast cancer and that inhibiting those two molecules can significantly improve patient survival outcomes. 

Tags: 

OHS Provides Easy Heart Health Tips at “DASH and Dine” Event

The lunchtime dash to a nearby eatery is a daily ritual at NCI at Frederick, but Occupational Health Services (OHS) recently showed employees a different, healthy kind of DASH—Dietary Approaches to Stop Hypertension. Employees who visited the educational lunch-hour event, called “DASH and Dine,” had the chance to speak with OHS staff about the benefits of the DASH Eating Plan, a diet developed by the National Heart, Lung, and Blood Institute (NHLBI).

Tags: 

(Updated) Targeted T-Cell Therapy Shows Promise Against Triple-Negative Breast Cancer

(Updated May 8) A study led by the Baylor College of Medicine and supported by NCI’s Center for Cancer Research (CCR) has demonstrated that chimeric antigen receptor (CAR) T-cell therapy can be used to treat solid triple-negative breast cancer (TNBC) tumors. The investigation is the first work using CAR T-cell therapy against TEM8, a cell surface protein that is frequently overexpressed both in TNBC cells and cells lining the blood vessels that sustain TNBC tumors.

Tags: 

Pages

Subscribe to Poster RSS